Indegene Share Price | Indegene Stock Screener
INDGN
Healthcare Technology
Share Price NSE
₹492.65
▲
4.15 (0.85%)
Share Price BSE
₹492.75
▲
4.20 (0.86%)
As of July 24, 2026, the Indegene share price (NSE: INDGN) is ₹492.65 on NSE and ₹492.75 on BSE, up 0.85% from the previous close, with shares trading between ₹486.10 and ₹495.00, and a 52-week range of ₹423.50–₹589.55.
Analyse Indegene share price performance and track historical price performance.
Use the Indegene stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Indegene Market Cap
₹11,927.24 Cr.
INDGN P/E Ratio (TTM)
30.51
Indegene P/B Ratio
3.90
EPS (TTM)
₹16.72
Dividend Yield
0.44%
Debt to Equity
0.15
INDGN 52 Week High
₹589.55
Indegene 52 Week Low
₹423.50
Operating Margin
14.00%
Profit Margin
7.89%
INDGN Revenue (TTM)
₹1,014.00
EBITDA
₹154.00
Net Income
₹80.00
Total Assets
₹4,620.00
Total Equity
₹3,139.00
Indegene Share Price Chart
Screen Indegene share price with an interactive chart. Analyse INDGN price trends and volatility across different timeframes.
Indegene Company Profile - Fundamental Screener
Screen Indegene company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INDGN shares.
Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical...more
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
Chairperson/CEO
Manish Gupta
ISIN
INE065X01017
Website
https://www.indegene.com
Indegene Balance Sheet Screener
Screen INDGN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 4,620 | 3,326 | 2,546 | 2,204 | 1,354 | 596 | 600 | 329 |
| Current Assets | 2,618 | 2,530 | 1,791 | 1,449 | 1,130 | 459 | 418 | 185 |
| Fixed Assets | 1,812 | 678 | 646 | 664 | 138 | 86 | 119 | 104 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 395 | 146 | 506 | 651 | 149 | 64 | 369 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 3,139 | 2,616 | 1,429 | 1,064 | 764 | 333 | -16 | 152 |
| Share Capital | 48 | 48 | 44 | 44 | 0 | 0 | 0 | 79 |
| Reserves & Surplus | 3,090 | 2,567 | 1,385 | 1,020 | 764 | 324 | -105 | 73 |
Indegene Income Statement Screener - Profit & Revenue Analysis
Screen Indegene income statement and profit fundamentals.
Analyze INDGN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Indegene share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,014 | 962 | 824 | 783 | 781 | 758 | 708 | 699 | 699 | 687 | 647 | 636 | 645 | 540 |
| Expenses | 860 | 783 | 664 | 606 | 608 | 589 | 561 | 548 | 534 | 525 | 515 | 511 | 535 | 413 |
| EBITDA | 154 | 179 | 160 | 177 | 173 | 170 | 148 | 151 | 164 | 162 | 133 | 125 | 111 | 127 |
| Operating Profit % | 14.00% | 17.00% | 17.00% | 20.00% | 20.00% | 18.00% | 18.00% | 19.00% | 21.00% | 22.00% | 19.00% | 16.00% | 15.00% | 21.00% |
| Depreciation | 42 | 40 | 23 | 22 | 21 | 20 | 19 | 20 | 19 | 18 | 20 | 20 | 20 | 10 |
| Interest | 7 | 5 | 4 | 4 | 3 | 3 | 4 | 12 | 12 | 12 | 12 | 13 | 12 | 2 |
| Profit Before Tax | 105 | 135 | 133 | 152 | 149 | 146 | 124 | 120 | 134 | 132 | 101 | 93 | 79 | 115 |
| Tax | 25 | 32 | 31 | 36 | 32 | 37 | 32 | 32 | 39 | 34 | 26 | 24 | 30 | 29 |
| Net Profit | 80 | 103 | 102 | 116 | 118 | 110 | 92 | 88 | 95 | 99 | 75 | 68 | 49 | 86 |
| EPS | 3.32 | 4.29 | 4.26 | 4.86 | 4.91 | 4.59 | 3.84 | 3.79 | 4.27 | 4.45 | 3.38 | 3.09 | 2.20 | 3.88 |
Indegene Cash Flow Screener - Liquidity Fundamentals
Screen INDGN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 442 | 508 | 130 | 297 | 172 | 22 | 65 |
| Investing Activities | -677 | -327 | -896 | -158 | -81 | -16 | -18 |
| Financing Activities | 288 | -66 | 333 | 234 | -132 | 136 | -21 |
| Net Cash Flow | 52 | 115 | -433 | 373 | -41 | 143 | 25 |
Indegene Shareholding Pattern Screener
See Indegene shareholding pattern with promoter, FII, and DII holdings.
Check Indegene promoter holding and ownership changes for INDGN on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 9.91% | 10.27% | 11.48% | 11.30% | 10.05% | 5.24% | 5.03% | 4.82% |
| DII Holding | 8.74% | 8.30% | 8.07% | 6.96% | 7.20% | 4.96% | 3.98% | 3.17% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.49% | 12.57% | 12.45% | 13.28% | 13.51% | 11.34% | 26.41% | 24.32% |
| Other Holding | 68.86% | 68.87% | 68.00% | 68.46% | 69.24% | 78.45% | 64.58% | 67.69% |
| Shareholder Count | 138,533 | 142,119 | 147,182 | 151,809 | 151,997 | 144,708 | 153,789 | 151,440 |
Indegene Share Dividend Screener - Share Yield Analysis
Check Indegene dividend history with payout and yield data.
View Indegene dividend details including ex-dates and amounts for INDGN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹2.25 | 0.44% |
| 2025-March | ₹2.00 | 0.46% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Indegene Stock Index Membership
See which indices include Indegene stock.
Check INDGN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSEIPO
BSE INDEX SMLCAP
NIFTY 500
NIFTY IPO
NIFTY MIDSML 400
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP
Indegene Market Events Screener - Corporate Actions
Get Indegene corporate actions including splits, bonuses, and buybacks.
Check Indegene stock events that may affect INDGN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-13 | 2026-08-13 | Annual General Meeting | NA | 0.11% |
| 2026-07-31 | 2026-07-31 | Dividend | ₹ 2.25 /share | 1.60% |
| 2026-07-30 | 2026-07-30 | Quarterly Result Announcement | NA | 2.38% |
| 2026-04-29 | 2026-04-29 | Quarterly Result Announcement | NA | 3.54% |
| 2026-01-29 | 2026-01-29 | Quarterly Result Announcement | NA | -1.13% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | -1.67% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | -2.22% |
| 2025-06-26 | 2025-06-26 | Annual General Meeting | NA | -4.70% |
| 2025-06-13 | 2025-06-13 | Dividend | ₹ 2.00 /share | 5.49% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | -0.50% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -6.18% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | 3.40% |
| 2024-09-06 | 2024-09-06 | Annual General Meeting | NA | 9.73% |
| 2022-11-17 | 2022-11-17 | Change Of Name | NA | - |
Indegene Competitors Screener - Peer Comparison
Screen INDGN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 16,385 | 52.79 | 3,809 | 2.56% | 317 | 36.39 |
| Indegene | 11,927 | 30.51 | 3,583 | 21.58% | 401 | 47.50 |
| Suven Life Sciences | 8,794 | -34.84 | 7 | -59.60% | -276 | 61.52 |
| Vimta Labs | 2,596 | 35.09 | 322 | 0.22% | 41 | 60.89 |
| Take Solutions | 305 | 27.88 | 54 | 431.27% | 11 | 27.68 |
| Bilcare | 145 | -8.40 | 734 | -9.05% | -21 | 49.17 |
| Jeevan Scientific Technology | 144 | 140.25 | 62 | 29.56% | 2 | 38.88 |
| Adeshwar Meditex | 25 | 33.09 | 56 | -33.21% | 1 | 24.11 |
| Vanta Bioscience | 18 | 168.60 | 2 | -13.33% | 0 | 19.48 |
Indegene Company Announcements - News Screener
Screen INDGN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-22 | Letter To Shareholders In Relation To Annual Report Of The Company For The Financial Year 2025-26 | - |
| 2026-07-22 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-07-22 | Reg. 34 (1) Annual Report. | - |
| 2026-07-22 | Notice Of The 28Th Annual General Meeting Of The Company | - |
| 2026-07-21 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-20 | Record Date For Payment Of Final Dividend | - |
| 2026-07-20 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-07-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-10 | Board Meeting Intimation for Consideration Of The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026 Along With The Limited Review Report Of The Auditors Thereon. | - |
| 2026-07-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-06 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-05 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-05-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |